| Literature DB >> 33994414 |
Hiroshi Yamasaki1, Hideki Ujiie1, Tatsuya Kato1, Yasuhiro Hida1, Kichizo Kaga1, Satoru Wakasa1, Yoshihiro Matsuno2.
Abstract
PURPOSE: Pulmonary nodules suspected to be cancerous are rarely diagnosed as pulmonary infarction (PI). This study examined the clinical, radiological, and laboratory data in cases diagnosed with PI to determine their potential utility as preoperative diagnostic markers. We also assessed factors affecting the postoperative course.Entities:
Keywords: deep venous thrombosis; pulmonary embolism; pulmonary infarction; venous thromboembolism
Mesh:
Year: 2021 PMID: 33994414 PMCID: PMC8684840 DOI: 10.5761/atcs.oa.20-00396
Source DB: PubMed Journal: Ann Thorac Cardiovasc Surg ISSN: 1341-1098 Impact factor: 1.520
Patient characteristics and radiological appearances
| Case | Age/sex | Symptom | BMI | Smoking (pack years) | Past medical history | Internal medicine | ECG | Cardiac echo | TBLB | Location | Max. size (mm) | Enlargement | Shape | HU (P/E) | SUV max |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 51/M | − | 21.7 | 0.5 | 25 yo infectious mononucleosis 50 yo dyslipidemia | − | N/A | − | >No malignancy | R. S4 | 20 × 12 | − | Round | 57/29 | 2.3 |
| 2 | 48/F | − | 29.4 | 5.5 | 26 yo cholelithiasis (operation) | − | CRBBB | − | Not performed | R. S6 | 9 × 7 | − | Round | 23/-34 | None |
| 3 | 74/M | − | 17.9 | 54.1 | 6 yo nephrotic syndrome 63 yo hemorrhagic gastric ulcer | − | N/A | N/A | No malignancy | >R. S3 | 17 × 13 | + | Trabecular | 19/24 | 3.1 |
| 4 | 64/M | − | 21 | 45 | 49 yo DM (insulin) 55 yo IgG4-related disease 62 yo, 64 yo pneumonia | Steroid (PSL 10 mg) | CRBBB | N/A | Not performed | L. S1+2 | 11 × 7 | − | Round | 60/49 | 2.6 |
BMI: body mass index; CRBBB: complete right bundle branch block; DM: diabetes mellitus; ECG: electrocardiogram; F: female; HU: Hounsfield unit; L: left; M: male; Max.: maximum; N/A: not applicable; PSL: prednisolone; R: right; SUVmax: maximum standardized uptake value (of 18F-Fluorodeoxyglucose-position emission tomography); TBLB: transbronchial lung biopsy; yo: years old
Preoperative laboratory data findings
| Case | WBC (cells × 109 L) | Neut (%) | RBC (×106) | Hgb (g/dL) | Hct (%) | Plt (×1000/μL) | PT (s) | APTT (s) | FDP (μg/mL) | Fibg (mg/dL) | D-dimer (μg/mL) | CEA (ng/mL) | SCC (ng/mL) | CYFRA (ng/mL) | ProGRP (pg/mL) | NSE (ng/mL) | pCO2 (mmHg) | pO2 (mmHg) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 3.6 | 55.2 | 4.77 | 15.6 | 45.5 | 209 | 12.1 | 36.6 | – | 199 L | – | 2.3 | 1 | 1.2 | 46.3 | 12.8 H | 46.5 H | 93.6 |
| 2 | 4.8 | 57.1 | 3.93 | 11.4 L | 34.6 L | 408 H | 10.8 | 29.6 | <2.6 | 203 | <0.32 | 0.9 L | N/A | 0.6 | N/A | N/A | 36.5 | 84.4 L |
| 3 | 5.6 | 50.3 | 4.57 | 16 | 45.8 | 130 L | 11.3 | 26.0 L | 3.5 | 200 | 1.71 H | 3.8 | 1.6 | 1.9 | 87.2 H | 10.3 | 38.7 | 91.3 |
| 4 | 8.2 | 71.5 | 3.82 L | 11.7 L | 35.5 L | 253 | 9.8 L | 30.2 | <2.6 | 230 | 0.43 | 2.1 | 1 | 3.2 | 36.8 | 10 | 46.2 H | 94.4 |
APTT: activated partial thromboplastin time; CEA: carcinoembryonic antigen; CYFRA: cytokeratin fragment; FDP: fibrin degradation product; Fibg: fibrinogen; Hct: hematocrit; Hgb: hemoglobin; Neut: neutrophil; NSE: neuron specific enolase; pCO2: partial pressure of arterial carbon dioxide; Plt: platelet; pO2: partial pressure of arterial oxygen; ProGRP: pro-gastrin- releasing peptide; PT: prothrombin time; RBC: red blood cell; SCC: squamous cell carcinoma antigen; WBC: white blood cell